GTC Biotherapeutics (fka GTCB)

[keitern]

No doubt GTC has done a great job of developing the company except in the one area of staying ahead of the curve on incremental financing IMO. Even to this day Cox is continuing his habit of moving ahead with programs just one step ahead of securing the proper funding. It is a common mistake but in one's personal life reality checks rather quickly, whereas in public corporations nowadays reality never seems to bite.